340 related articles for article (PubMed ID: 14668794)
1. CD95/Fas signaling in human melanoma cells: conditional expression of CD95L/FasL overcomes the intrinsic apoptosis resistance of malignant melanoma and inhibits growth and progression of human melanoma xenotransplants.
Eberle J; Fecker LF; Hossini AM; Wieder T; Daniel PT; Orfanos CE; Geilen CC
Oncogene; 2003 Dec; 22(57):9131-41. PubMed ID: 14668794
[TBL] [Abstract][Full Text] [Related]
2. Caspase-independent induction of apoptosis in human melanoma cells by the proapoptotic Bcl-2-related protein Nbk / Bik.
Oppermann M; Geilen CC; Fecker LF; Gillissen B; Daniel PT; Eberle J
Oncogene; 2005 Nov; 24(49):7369-80. PubMed ID: 16007125
[TBL] [Abstract][Full Text] [Related]
3. C2-ceramide signaling in glioma cells: synergistic enhancement of CD95-mediated, caspase-dependent apoptosis.
Wagenknecht B; Roth W; Gulbins E; Wolburg H; Weller M
Cell Death Differ; 2001 Jun; 8(6):595-602. PubMed ID: 11536010
[TBL] [Abstract][Full Text] [Related]
4. FR901228 induces tumor regression associated with induction of Fas ligand and activation of Fas signaling in human osteosarcoma cells.
Imai T; Adachi S; Nishijo K; Ohgushi M; Okada M; Yasumi T; Watanabe K; Nishikomori R; Nakayama T; Yonehara S; Toguchida J; Nakahata T
Oncogene; 2003 Dec; 22(58):9231-42. PubMed ID: 14647441
[TBL] [Abstract][Full Text] [Related]
5. The regulation of CD95 ligand expression and function in CTL.
Li JH; Rosen D; Ronen D; Behrens CK; Krammer PH; Clark WR; Berke G
J Immunol; 1998 Oct; 161(8):3943-9. PubMed ID: 9780162
[TBL] [Abstract][Full Text] [Related]
6. Different susceptibility of cytotoxic T cells to CD95 (Fas/Apo-1) ligand-mediated cell death after activation in vitro versus in vivo.
Ehl S; Hoffmann-Rohrer U; Nagata S; Hengartner H; Zinkernagel R
J Immunol; 1996 Apr; 156(7):2357-60. PubMed ID: 8786290
[TBL] [Abstract][Full Text] [Related]
7. Suppression of cFLIP is sufficient to sensitize human melanoma cells to TRAIL- and CD95L-mediated apoptosis.
Geserick P; Drewniok C; Hupe M; Haas TL; Diessenbacher P; Sprick MR; Schön MP; Henkler F; Gollnick H; Walczak H; Leverkus M
Oncogene; 2008 May; 27(22):3211-20. PubMed ID: 18084329
[TBL] [Abstract][Full Text] [Related]
8. CD95 ligand expression in dedifferentiated breast cancer.
Müschen M; Moers C; Warskulat U; Niederacher D; Betz B; Even J; Lim A; Josien R; Beckmann MW; Häussinger D
J Pathol; 1999 Nov; 189(3):378-86. PubMed ID: 10547600
[TBL] [Abstract][Full Text] [Related]
9. T cell activation-induced and HIV tat-enhanced CD95(APO-1/Fas) ligand transcription involves NF-kappaB.
Li-Weber M; Laur O; Dern K; Krammer PH
Eur J Immunol; 2000 Feb; 30(2):661-70. PubMed ID: 10671224
[TBL] [Abstract][Full Text] [Related]
10. Irradiation induced clonogenic cell death of human malignant glioma cells does not require CD95/CD95L interactions.
Streffer JR; Schuster M; Pohl U; Belka C; Dichgans J; Bamberg M; Weller M
Anticancer Res; 1999; 19(6B):5265-9. PubMed ID: 10697547
[TBL] [Abstract][Full Text] [Related]
11. Differential activation of the Fas/CD95 pathway by Ad-p53 in human gliomas.
Cerrato JA; Khan T; Koul D; Lang FF; Conrad CA; Yung WK; Liu TJ
Int J Oncol; 2004 Feb; 24(2):409-17. PubMed ID: 14719118
[TBL] [Abstract][Full Text] [Related]
12. Promotion of activated human B cell apoptosis and inhibition of Ig production by soluble CD95 ligand: CD95-based downregulation of Ig production need not culminate in activated B cell death.
Stohl W; Xu D; Starling GC; Casali P; Kiener PA
Cell Immunol; 2000 Jul; 203(1):1-11. PubMed ID: 10915556
[TBL] [Abstract][Full Text] [Related]
13. Physalis peruviana extract induces apoptosis in human Hep G2 cells through CD95/CD95L system and the mitochondrial signaling transduction pathway.
Wu SJ; Ng LT; Lin DL; Huang SN; Wang SS; Lin CC
Cancer Lett; 2004 Nov; 215(2):199-208. PubMed ID: 15488639
[TBL] [Abstract][Full Text] [Related]
14. The influence of CD95L expression on tumor rejection in mice.
Igney FH; Behrens CK; Krammer PH
Eur J Immunol; 2003 Oct; 33(10):2811-21. PubMed ID: 14515265
[TBL] [Abstract][Full Text] [Related]
15. Efficient and selective tumor cell lysis and induction of apoptosis in melanoma cells by a conditional replication-competent CD95L adenovirus.
Fecker LF; Schmude M; Jost S; Hossini AM; Picó AH; Wang X; Schwarz C; Fechner H; Eberle J
Exp Dermatol; 2010 Aug; 19(8):e56-66. PubMed ID: 19725869
[TBL] [Abstract][Full Text] [Related]
16. Cell density modulates apoptosis in human articular chondrocytes.
Kühn K; Hashimoto S; Lotz M
J Cell Physiol; 1999 Sep; 180(3):439-47. PubMed ID: 10430184
[TBL] [Abstract][Full Text] [Related]
17. CD95 apoptosis resistance in certain cells can be overcome by noncanonical activation of caspase-8.
Barnhart BC; Pietras EM; Algeciras-Schimnich A; Salmena L; Sayama K; Hakem R; Peter ME
Cell Death Differ; 2005 Jan; 12(1):25-37. PubMed ID: 15499374
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of growth of melanoma cells by CD95 (Fas/APO-1) gene transfer in vivo.
Aragane Y; Maeda A; Cui CY; Tezuka T; Kaneda Y; Schwarz T
J Invest Dermatol; 2000 Dec; 115(6):1008-14. PubMed ID: 11121134
[TBL] [Abstract][Full Text] [Related]
19. Fas-mediated apoptosis of melanoma cells and infiltrating lymphocytes in human malignant melanomas.
Shukuwa T; Katayama I; Koji T
Mod Pathol; 2002 Apr; 15(4):387-96. PubMed ID: 11950912
[TBL] [Abstract][Full Text] [Related]
20. Production and pro-apoptotic activity of soluble CD95 ligand in pancreatic carcinoma.
Bellone G; Smirne C; Carbone A; Mareschi K; Dughera L; Farina EC; Alabiso O; Valente G; Emanuelli G; Rodeck U
Clin Cancer Res; 2000 Jun; 6(6):2448-55. PubMed ID: 10873098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
